A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
Phase 3
Completed
- Conditions
- DementiaAlzheimer DiseaseVascular Dementia
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2010-11-19
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 344
- Registration Number
- NCT00249158
An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection
Phase 2
Completed
- Conditions
- HIV-1
- Interventions
- Genetic: OZ1Other: PlaceboGenetic: CD34+ cells
- First Posted Date
- 2003-12-31
- Last Posted Date
- 2016-06-20
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 1
- Registration Number
- NCT00074997
© Copyright 2025. All Rights Reserved by MedPath